Selected research
Industry Research
DNA/RNA Quality Control Industry Research Report 2026
Market perspective
The global DNA/RNA Quality Control market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the DNA/RNA Quality Control market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the DNA/RNA Quality Control market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the DNA/RNA Quality Control market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of DNA/RNA Quality Control include BigOmics Analytics, Cambridge Genomic Services, Creative Biogene, Eurofins Genomics, Genomics, Hokkaido System Science, LC Sciences, Life Magnetics and Norgen Biotek, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global DNA/RNA Quality Control market in terms of revenue (US$ million) and, where applicable, service volume (Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to DNA/RNA Quality Control.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
DNA/RNA Quality Control Market by Company
BigOmics Analytics
Cambridge Genomic Services
Creative Biogene
Eurofins Genomics
Genomics
Hokkaido System Science
LC Sciences
Life Magnetics
Norgen Biotek
Omega Bioservices
PathoQuest
QIAGEN
QIMA Life Sciences
Thermo Fisher Scientific
DNA/RNA Quality Control Segment by Type
DNA Quality Control
RNA Quality Control
DNA/RNA Quality Control Segment by Application
Medical Diagnostics
Biological Research
Genomics
DNA/RNA Quality Control Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA/RNA Quality Control market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA/RNA Quality Control and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA/RNA Quality Control.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of DNA/RNA Quality Control companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Quality Control
- RNA Quality Control
Applications
- Medical Diagnostics
- Biological Research
- Genomics
Companies covered
- BigOmics Analytics
- Cambridge Genomic Services
- Creative Biogene
- Eurofins Genomics
- Genomics
- Hokkaido System Science
- LC Sciences
- Life Magnetics
- Norgen Biotek
- Omega Bioservices
- PathoQuest
- QIAGEN
- QIMA Life Sciences
- Thermo Fisher Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 DNA/RNA Quality Control by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 DNA Quality Control
- 2.2.3 RNA Quality Control
- 2.3 DNA/RNA Quality Control by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical Diagnostics
- 2.3.3 Biological Research
- 2.3.4 Genomics
- 2.4 Assumptions and Limitations
3 DNA/RNA Quality Control Breakdown Data by Type
- 3.1 Global DNA/RNA Quality Control Historic Market Size by Type (2021-2026)
- 3.2 Global DNA/RNA Quality Control Forecasted Market Size by Type (2027-2032)
4 DNA/RNA Quality Control Breakdown Data by Application
- 4.1 Global DNA/RNA Quality Control Historic Market Size by Application (2021-2026)
- 4.2 Global DNA/RNA Quality Control Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global DNA/RNA Quality Control Market Perspective (2021-2032)
- 5.2 Global DNA/RNA Quality Control Growth Trends by Region
- 5.2.1 Global DNA/RNA Quality Control Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 DNA/RNA Quality Control Historic Market Size by Region (2021-2026)
- 5.2.3 DNA/RNA Quality Control Forecasted Market Size by Region (2027-2032)
- 5.3 DNA/RNA Quality Control Market Dynamics
- 5.3.1 DNA/RNA Quality Control Industry Trends
- 5.3.2 DNA/RNA Quality Control Market Drivers
- 5.3.3 DNA/RNA Quality Control Market Challenges
- 5.3.4 DNA/RNA Quality Control Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top DNA/RNA Quality Control Players by Revenue
- 6.1.1 Global Top DNA/RNA Quality Control Players by Revenue (2021-2026)
- 6.1.2 Global DNA/RNA Quality Control Revenue Market Share by Players (2021-2026)
- 6.2 Global DNA/RNA Quality Control Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of DNA/RNA Quality Control Head Office and Area Served
- 6.4 Global DNA/RNA Quality Control Players, Product Type & Application
- 6.5 Global DNA/RNA Quality Control Manufacturers Established Date
- 6.6 Global DNA/RNA Quality Control Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America DNA/RNA Quality Control Market Size (2021-2032)
- 7.2 North America DNA/RNA Quality Control Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America DNA/RNA Quality Control Market Size by Country (2021-2026)
- 7.4 North America DNA/RNA Quality Control Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe DNA/RNA Quality Control Market Size (2021-2032)
- 8.2 Europe DNA/RNA Quality Control Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe DNA/RNA Quality Control Market Size by Country (2021-2026)
- 8.4 Europe DNA/RNA Quality Control Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific DNA/RNA Quality Control Market Size (2021-2032)
- 9.2 Asia-Pacific DNA/RNA Quality Control Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific DNA/RNA Quality Control Market Size by Country (2021-2026)
- 9.4 Asia-Pacific DNA/RNA Quality Control Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America DNA/RNA Quality Control Market Size (2021-2032)
- 10.2 South America DNA/RNA Quality Control Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America DNA/RNA Quality Control Market Size by Country (2021-2026)
- 10.4 South America DNA/RNA Quality Control Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa DNA/RNA Quality Control Market Size (2021-2032)
- 11.2 Middle East & Africa DNA/RNA Quality Control Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa DNA/RNA Quality Control Market Size by Country (2021-2026)
- 11.4 Middle East & Africa DNA/RNA Quality Control Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BigOmics Analytics
- 12.1.1 BigOmics Analytics Company Information
- 12.1.2 BigOmics Analytics Business Overview
- 12.1.3 BigOmics Analytics Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.1.4 BigOmics Analytics DNA/RNA Quality Control Product Portfolio
- 12.1.5 BigOmics Analytics Recent Developments
- 12.2 Cambridge Genomic Services
- 12.2.1 Cambridge Genomic Services Company Information
- 12.2.2 Cambridge Genomic Services Business Overview
- 12.2.3 Cambridge Genomic Services Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.2.4 Cambridge Genomic Services DNA/RNA Quality Control Product Portfolio
- 12.2.5 Cambridge Genomic Services Recent Developments
- 12.3 Creative Biogene
- 12.3.1 Creative Biogene Company Information
- 12.3.2 Creative Biogene Business Overview
- 12.3.3 Creative Biogene Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.3.4 Creative Biogene DNA/RNA Quality Control Product Portfolio
- 12.3.5 Creative Biogene Recent Developments
- 12.4 Eurofins Genomics
- 12.4.1 Eurofins Genomics Company Information
- 12.4.2 Eurofins Genomics Business Overview
- 12.4.3 Eurofins Genomics Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.4.4 Eurofins Genomics DNA/RNA Quality Control Product Portfolio
- 12.4.5 Eurofins Genomics Recent Developments
- 12.5 Genomics
- 12.5.1 Genomics Company Information
- 12.5.2 Genomics Business Overview
- 12.5.3 Genomics Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.5.4 Genomics DNA/RNA Quality Control Product Portfolio
- 12.5.5 Genomics Recent Developments
- 12.6 Hokkaido System Science
- 12.6.1 Hokkaido System Science Company Information
- 12.6.2 Hokkaido System Science Business Overview
- 12.6.3 Hokkaido System Science Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.6.4 Hokkaido System Science DNA/RNA Quality Control Product Portfolio
- 12.6.5 Hokkaido System Science Recent Developments
- 12.7 LC Sciences
- 12.7.1 LC Sciences Company Information
- 12.7.2 LC Sciences Business Overview
- 12.7.3 LC Sciences Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.7.4 LC Sciences DNA/RNA Quality Control Product Portfolio
- 12.7.5 LC Sciences Recent Developments
- 12.8 Life Magnetics
- 12.8.1 Life Magnetics Company Information
- 12.8.2 Life Magnetics Business Overview
- 12.8.3 Life Magnetics Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.8.4 Life Magnetics DNA/RNA Quality Control Product Portfolio
- 12.8.5 Life Magnetics Recent Developments
- 12.9 Norgen Biotek
- 12.9.1 Norgen Biotek Company Information
- 12.9.2 Norgen Biotek Business Overview
- 12.9.3 Norgen Biotek Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.9.4 Norgen Biotek DNA/RNA Quality Control Product Portfolio
- 12.9.5 Norgen Biotek Recent Developments
- 12.10 Omega Bioservices
- 12.10.1 Omega Bioservices Company Information
- 12.10.2 Omega Bioservices Business Overview
- 12.10.3 Omega Bioservices Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.10.4 Omega Bioservices DNA/RNA Quality Control Product Portfolio
- 12.10.5 Omega Bioservices Recent Developments
- 12.11 PathoQuest
- 12.11.1 PathoQuest Company Information
- 12.11.2 PathoQuest Business Overview
- 12.11.3 PathoQuest Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.11.4 PathoQuest DNA/RNA Quality Control Product Portfolio
- 12.11.5 PathoQuest Recent Developments
- 12.12 QIAGEN
- 12.12.1 QIAGEN Company Information
- 12.12.2 QIAGEN Business Overview
- 12.12.3 QIAGEN Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.12.4 QIAGEN DNA/RNA Quality Control Product Portfolio
- 12.12.5 QIAGEN Recent Developments
- 12.13 QIMA Life Sciences
- 12.13.1 QIMA Life Sciences Company Information
- 12.13.2 QIMA Life Sciences Business Overview
- 12.13.3 QIMA Life Sciences Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.13.4 QIMA Life Sciences DNA/RNA Quality Control Product Portfolio
- 12.13.5 QIMA Life Sciences Recent Developments
- 12.14 Thermo Fisher Scientific
- 12.14.1 Thermo Fisher Scientific Company Information
- 12.14.2 Thermo Fisher Scientific Business Overview
- 12.14.3 Thermo Fisher Scientific Revenue in DNA/RNA Quality Control Business (2021-2026)
- 12.14.4 Thermo Fisher Scientific DNA/RNA Quality Control Product Portfolio
- 12.14.5 Thermo Fisher Scientific Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst